Avian Influenza A (H7N9) ValuPanel™ Reagents* are now part of the ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures discriminate the H7N9 virus that causes avian (bird) flu, and capable of infecting humans when circulating in 2013. This virus differs from earlier avian flu strains including H5N1, and others found only in birds.
This panel consists of dual-labeled BHQ® probes for use in real-time qPCR to discriminate H7N9 viral strains. This new ValuPanel contains probes and primers based on genetic signatures for the following:
- Universal Influenza A
- Influenza A subtypes H7 and N9
- Human RNase P (Extraction Control)
Oligonucleotide sequences for the H7 and N9 subtypes were designed by the World Health Organization (WHO) Collaborating Center for Reference and Research on Influenza at the Chinese National Influenza Center (CNIC) in Beijing, China. Universal Influenza A and RNase P sequences were designed by and licensed from the US Centers for Disease Control and Prevention (CDC**). Sequences for the forward and reverse primers for the N9 subtype correspond to the CNIC-WHO’s optimized sequences as listed in the revised protocol dated April 15th, 2013. All probes are labeled with FAM and Black Hole Quencher® (BHQ®) dyes, and are HPLC purified. LGC Biosearch is the inventor of the BHQ dyes and is the sole manufacturer of the true dark quencher currently used for the labeled probes included in the Avian Influenza A (H7N9) panel.
*For Research Use Only. Not for use in diagnostic procedures.
**CDC does not endorse products or services.
Order Avian Influenza A (H7N9) ValuPanel Reagents Today!
Want to purchase BHQ Probes to detect Avian Flu (H7N9) virus? Simply add the individual reagents or the entire ValuPanel Reagent set to your online shopping cart. ValuPanel Reagents ship the same day via FedEx Priority (unless specified otherwise) for orders placed before 2:00 PM (PST).